Feasibility of 18F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times
M Grkovski, J Schwartz, M Gönen… - Journal of Nuclear …, 2016 - Soc Nuclear Med
18F-fluoromisonidazole dynamic PET (dPET) is used to identify tumor hypoxia
noninvasively. Its routine clinical implementation, however, has been hampered by the long …
noninvasively. Its routine clinical implementation, however, has been hampered by the long …
Multiparametric imaging of tumor hypoxia and perfusion with 18F-fluoromisonidazole dynamic PET in head and neck cancer
Tumor hypoxia and perfusion are independent prognostic indicators of patient outcome. We
developed the methodology for and investigated the utility of multiparametric imaging of …
developed the methodology for and investigated the utility of multiparametric imaging of …
Pharmacokinetic analysis of hypoxia 18F-fluoromisonidazole dynamic PET in head and neck cancer
This study used pharmacokinetic analysis of 18F-labeled fluoromisonidazole (18F-FMISO)
dynamic PET to assist the identification of regional tumor hypoxia and to investigate the …
dynamic PET to assist the identification of regional tumor hypoxia and to investigate the …
Pharmacokinetic analysis of dynamic 18F-fluoromisonidazole PET data in non–small cell lung cancer
J Schwartz, M Grkovski, A Rimner… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Hypoxic tumors exhibit increased resistance to radiation, chemical, and immune therapies.
18F-fluoromisonidazole (18F-FMISO) PET is a noninvasive, quantitative imaging technique …
18F-fluoromisonidazole (18F-FMISO) PET is a noninvasive, quantitative imaging technique …
Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer
Purpose There is growing recognition that biologic features of the tumor microenvironment
affect the response to cancer therapies and the outcome of cancer patients. In head and …
affect the response to cancer therapies and the outcome of cancer patients. In head and …
[HTML][HTML] Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
D Thorwarth, SM Eschmann, J Scheiderbauer… - BMC cancer, 2005 - Springer
Background Hypoxia compromises local control in patients with head-and-neck cancer
(HNC). In order to determine the value of [18 F]-fluoromisonidazole (Fmiso) with regard to …
(HNC). In order to determine the value of [18 F]-fluoromisonidazole (Fmiso) with regard to …
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy
SM Eschmann, F Paulsen, M Reimold… - Journal of nuclear …, 2005 - Soc Nuclear Med
In radiotherapy of head and neck cancer (HNC) and non-small cell lung cancer (NSCLC),
hypoxia is known to be an important prognostic factor for long-term survival and local tumor …
hypoxia is known to be an important prognostic factor for long-term survival and local tumor …
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer
S Okamoto, T Shiga, K Yasuda, YM Ito… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Tumor hypoxia is well known to be radiation resistant. 18F-fluoromisonidazole (18F-FMISO)
PET has been used for noninvasive evaluation of hypoxia. Quantitative evaluation of 18F …
PET has been used for noninvasive evaluation of hypoxia. Quantitative evaluation of 18F …
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging
This paper systematically evaluates a pharmacokinetic compartmental model for identifying
tumor hypoxia using dynamic positron emission tomography (PET) imaging with 18 F …
tumor hypoxia using dynamic positron emission tomography (PET) imaging with 18 F …
Comparison of DCE‐MRI kinetic parameters and FMISO‐PET uptake parameters in head and neck cancer patients
U Simoncic, S Leibfarth, S Welz, N Schwenzer… - Medical …, 2017 - Wiley Online Library
Purpose Tumor hypoxia is a major cause of radiation resistance, often present in various
solid tumors. Dynamic [18F]‐fluoromisonidazole (FMISO) PET imaging is able to reliably …
solid tumors. Dynamic [18F]‐fluoromisonidazole (FMISO) PET imaging is able to reliably …
Related searches
- kinetic modeling acquisition times
- neck cancer acquisition times
- kinetic modeling neck cancer
- neck cancer dynamic pet
- neck cancer tumor hypoxia
- neck cancer multiparametric imaging
- neck cancer pharmacokinetic analysis
- neck cancer dce mri
- neck cancer high reproducibility
- neck cancer early response
- neck cancer prognostic impact
- dynamic pet tumor hypoxia
- dynamic pet multiparametric imaging
- multiparametric imaging tumor hypoxia
- high reproducibility tumor hypoxia
- dynamic pet early response